The U.S. FDA announced the availability of the Express mobile application, enabling the public to search for information about FDA-approved brand and generic prescription and over-the-counter human drugs and biological therapeutic products.
The FDA currently operates the , which includes information about drug products approved by the agency, including patient information, drug labeling, approval letters, reviews and other information.
The Express mobile app is a streamlined version of , allowing users to search on their mobile devices for certain product information based on product name, active ingredient or application number using a single search box. Some information (like labeling supplements and approval letters) won’t be available on the app, but can be found on the webpage.
The app will also feature the most recent product approvals, within seven days, links to the glossary and frequently asked questions. It will also provide contact information for the FDA’s consumer information office, the Division of Drug Information.
“Consumers are embracing digital health technologies to inform everyday decisions. From fitness trackers to mobile applications tracking insulin administration, these digital tools can empower consumers with a wealth of valuable health information. Advancing mobile apps that inform people about their health and medical choices represents a significant public health opportunity and is a high priority for the FDA,” says FDA Commissioner Scott Gottlieb, M.D.